Ceredex Value Advisors Boosts Stake in Humana

Institutional investor increases position in insurance provider by 19.4% in Q3

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Ceredex Value Advisors LLC, an institutional investor, increased its stake in Humana Inc. (NYSE:HUM) by 19.4% in the third quarter, according to a recent SEC filing. The firm now owns 85,565 shares of the insurance provider's stock, worth approximately $22.3 million.

Why it matters

Humana is one of the largest health insurance providers in the United States, offering Medicare Advantage plans, prescription drug coverage, and commercial group health plans. Institutional investors closely monitor changes in ownership of major healthcare companies like Humana, as it can signal broader market trends and investor sentiment.

The details

According to the 13F filing, Ceredex Value Advisors purchased an additional 13,915 shares of Humana stock during the third quarter, bringing its total position to 85,565 shares. This represents about 0.07% of Humana's outstanding shares. The filing shows Ceredex Value Advisors is one of Humana's larger institutional investors.

  • Ceredex Value Advisors increased its Humana stake in the 3rd quarter of 2026.

The players

Ceredex Value Advisors LLC

An institutional investment firm that manages a portfolio of stocks, including a position in Humana Inc.

Humana Inc.

A major health insurance provider in the United States, offering Medicare Advantage plans, prescription drug coverage, and commercial group health plans.

Got photos? Submit your photos here. ›

The takeaway

The increase in Ceredex Value Advisors' Humana stake suggests the institutional investor sees value in the insurance provider's business and growth prospects, even as the stock has faced some market volatility recently.